What factors affect Lortab dosage?

Available only on prescription, Lortab® depends on the narcotic properties of hydrocodel for most of its pain relief properties and includes acetaminophene primarily to prevent abuse by limiting the increase in dose due to the risk of overdose. The frequency and intensity of side effects increase linearly as Lortab® doses increase, which is suitable to use the lowest effective dose. Some factors that may affect the initial Lortab® dosage are age, patient's weight, drug regime, tolerance to painkillers of opioid pain and the level of liver or kidney function.

The standard dosage of Lortab® recommended by the manufacturer for use in pain treatment in adult patients is one tablet administered every four to six hours as needed. The dose may be increased if it is unsuccessful in controlling the patient's pain and may be required to increase the development of drug tolerance. During the 24 -hour period, the total dosage of Lortab® Administred should not exceedSix tablets due to the risk of acetaminophene toxicity. When switching the patient to a drug from other narcotic drugs from the area compared to opioid cross toleration, a larger initial dose of Lortab® may be required. If the use is interrupted, it may be necessary to gradually reduce the dose to reduce the symptoms of opiate collection in the patient.

Patients with reduced kidney function may be necessary to use lower Lortab® dosage due to reduced ability to secrete drugs and their metabolites into the urine. Because the drugs are metabolized in the liver and can cause high doses liver damage, patients with reduced liver levels may also have to have a reduced liver level. Geriatric patients or patients with hypothyroidism, prostate hypertrophy, addison disease, pulmonary disease or urinary uric apartment should be given the lowest possible possibility of initially, with an increase in dose carefully monitored.

Due to your own riskLiver damage that represents high doses of acetaminophene, alcohol consumption together with Lortab® dramatically increases the risk of hepatotoxicity and other risk of coma, respiratory complications, damage to the central nervous system and damage to the gastrointestinal. It is known that many other drugs are dangerously interacting with Lortab®, including amphetamines, cocaine, ritalin®, barbitates and benzodiazepines, and create a wide range of unfavorable and potentially fatal reactions.

Lortab® is a combination of drugs acetaminophene and hydrocodes that are used to treat medium to severe pain. Normal side effects include sweating, drowsiness, constipation, euphoria, dizziness, itching, lightness and nausea. More serious side effects are vomiting, mood change, permanently reduced testosterone levels, blood disorders, irregular breathing, anxiety, lethargy, difficult urination and skin rash.